A prospective study of the prevalence of nonclassical congenital adrenal hyperplasia among women presenting with hyperandrogenic symptoms and signs

Journal of Clinical Endocrinology and Metabolism

Volumn 93, Issue 2, 2008, Pages 527-533

  Escobar Morreale, Héctor F ^a   Sanchón, Raul ^a   San Millán, José L ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; CORTODOXONE; HYDROXYPROGESTERONE; STEROID 11BETA MONOOXYGENASE; STEROID 21 MONOOXYGENASE;

ACNE; ADRENAL HYPERPLASIA; ADULT; ALOPECIA; ARTICLE; CONTROLLED STUDY; FEMALE; HIRSUTISM; HUMAN; HYPERANDROGENISM; MAJOR CLINICAL STUDY; MENSTRUATION DISORDER; NONCLASSICAL CONGENITAL ADRENAL HYPERPLASIA; PREVALENCE; PRIORITY JOURNAL;

EID: 39049105205     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2007-2053     Document Type: Article

References (42)

1. Carmina E, Lobo RA 1999 Polycystic ovary syndrome (PCOS): arguably the most common endocrinopathy is associated with significant morbidity in women. J Clin Endocrinol Metab 84:1897-1899
2. Asunción M, Calvo RM, San Millán JL, Sancho J, Avila S, Escobar-Morreale HF 2000 A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab 85:2434-2438
3. Diamanti-Kandarakis E, Christakou C 2006 Prevalence, definition and clinical manifestations of polycystic ovary syndrome. Endocrinol Nutr 53(Suppl 1):25-33
4. Ehrmann DA 2005 Polycystic ovary syndrome. N Engl J Med 352:1223-1236
5. Zawadzki JK, Dunaif A 1992 Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A, Givens JR, Haseltine FP, Merriam GR, eds. Polycystic ovary syndrome. Boston, MA: Blackwell Scientific; 377-384
6. The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group 2004 Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19:41-47
7. Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, Janssen OE, Legro RS, Norman RJ, Taylor AE, Witchel SF 2006 Position statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab 91:4237-4245
8. Nieman LK 2007 Adrenal steroid biosynthesis and congenital adrenal hyperplasia. In: Rose B, ed. UpToDate. Waltham, MA: UpToDate, Inc.
9. White PC, Curnow KM, Pascoe L 1994 Disorders of steroid 11β-hydroxylase isozymes. Endocr Rev 15:421-438
10. Hatch R, Rosenfield RL, Kim MH, Tredway D 1981 Hirsutism: implications, etiology, and management. Am J Obstet Gynecol 140:815-830
11. Goodman A 2007 Terminology and evaluation of abnormal uterine bleeding in premenopausal women. In: Rose BD, ed. UpToDate. Waltham, MA: UpToDate, Inc.
12. Escobar-Morreale HF, San Millán JL, Smith RR, Sancho J, Witchel SF 1999 The presence of the 21-hydroxylase deficiency carrier status in hirsute women: phenotype-genotype correlations. Fertil Steril 72:629-638
13. Vermeulen A, Verdonck L, Kaufman JM 1999 A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 84:3666-3672
14. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC 1985 Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma insulin and glucose concentrations in man. Diabetologia 28:412-419
15. Carmina E 2006 Mild androgen phenotypes. Best Pract Res Clin Endocrinol Metab 20:207-220
16. Azziz R, Carmina E, Sawaya ME 2000 Idiopathic hirsutism. Endocr Rev 21:347-362
17. Macklon NS, Fauser BC 2007 Overview of ovulation induction. In: Rose BD, ed. UpToDate. Waltham, MA: UpToDate, Inc.
18. Azziz R, Dewailly D, Owerbach D 1994 Nonclassic adrenal hyperplasia: current concepts. J Clin Endocrinol Metab 78:810-815
19. Escobar-Morreale HF 2004 Macroprolactinemia in women presenting with hyperandrogenic symptoms: implications for the management of polycystic ovary syndrome. Fertil Steril 82:1697-1699
20. Ezquieta B, Cueva E, Varela J, Oliver A, Fernandez J, Jariego C 2002 Nonclassical 21-hydroxylase deficiency in children: association of adrenocorticotropic hormone-stimulated 17-hydroxyprogesterone with the risk of compound heterozygosity with severe mutations. Acta Paediatr 91:892-898
21. Ezquieta B, Oliver A, Gracia R, Gancedo PG 1995 Analysis of steroid 21-hydroxylase gene mutations in the Spanish population. Hum Genet 96:198-204
22. Beck JR, Shultz EK 1986 The use of relative operating characteristic (ROC) curves in test performance evaluation. Arch Pathol Lab Med [Erratum (1986) 110:958] 110:13-20
23. Metz CE 1978 Basic principles of ROC analysis. Semin Nucl Med 8:283-298
24. Hanley JA, McNeil BJ 1982 The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143:29-36
25. Azziz R, Zacur HA 1989 21-Hydroxylase deficiency in female hyperandrogenism: screening and diagnosis. J Clin Endocrinol Metab 69:577-584
26. Dewailly D, Vantyghem-Haudiquet MC, Sainsard C, Buvat J, Cappoen JP, Ardaens K, Racadot A, Lefebvre J, Fossati P 1986 Clinical and biological phenotypes in late-onset 21-hydroxylase deficiency. J Clin Endocrinol Metab 63:418-423
27. Cobin RH, Futterweit W, Fiedler RP, Thornton JC 1985 Adrenocorticotropic hormone testing in idiopathic hirsutism and polycystic ovarian disease: a test of limited usefulness. Fertil Steril 44:224-226
28. Kuttenn F, Couillin P, Girard F, Billaud L, Vincens M, Boucekkine C, Thalabard J, Maudelonde T, Spritzer P, Mowszowicz I, Boué A, Mauvais-Jarvis P 1985 Late-onset adrenal hyperplasia in hirsutism. N Engl J Med 313:224-231
29. Benjamin F, Deutsch S, Saperstein H, Seltzer VL 1986 Prevalence of and markers for the attenuated form of congenital adrenal hyperplasia and hyperprolactinemia masquerading as polycystic ovarian disease. Fertil Steril 46:215-221
30. Carmina E, Malizia G, Pagano M, Janni A 1988 Prevalence of late-onset 11β-hydroxylase deficiency in hirsute patients. J Endocrinol Invest 11:595-598
31. Conway GS, Honour JW, Jacobs HS 1989 Heterogeneity of the polycystic ovary syndrome: clinical, endocrine and ultrasound features in 556 patients. Clin Endocrinol (Oxf) 30:459-470
32. Azziz R, Boots LR, Parker Jr CR, Bradley Jr E, Zacur HA 1991 11 beta-hydroxylase deficiency in hyperandrogenism. Fertil Steril 55:733-741
33. O'Driscoll JB, Mamtora H, Higginson J, Pollock A, Kane J, Anderson DC 1994 A prospective study of the prevalence of clear-cut endocrine disorders and polycystic ovaries in 350 patients presenting with hirsutism or androgenic alopecia. Clin Endocrinol (Oxf) 41:231-236
34. Moran C, Tapia MC, Hernandez E, Vazquez G, Garcia HE, Bermudez JA 1994 Etiological review of hirsutism in 250 patients. Arch Med Res 25:311-314
35. Balen AH, Conway GS, Kaltsas G, Techatrasak K, Manning PJ, West C, Jacobs HS 1995 Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients. Hum Reprod 10:2107-2111
36. Sahin Y, Kelestimur F 1997 The frequency of late-onset 21-hydroxylase and 11 beta-hydroxylase deficiency inwomenwith polycystic ovary syndrome. Eur J Endocrinol 137:670-674
37. Romaguera J, Moran C, Diaz-Montes TP, Hines GA, Cruz RI, Azziz R 2000 Prevalence of 21-hydroxylase-deficient nonclassic adrenal hyperplasia and insulin resistance among hirsutewomenfrom Puerto Rico. Fertil Steril 74:59-62
38. Azziz R, Sanchez LA, Knochenhauer ES, Moran C, Lazenby J, Stephens KC, Taylor K, Boots LR 2004 Androgen excess in women: experience with over 1000 consecutive patients. J Clin Endocrinol Metab 89:453-462
39. Glintborg D, Henriksen JE, Andersen M, Hagen C, Hangaard J, Rasmussen PE, Schousboe K, Hermann AP 2004 Prevalence of endocrine diseases and abnormal glucose tolerance tests in 340 Caucasian premenopausal women with hirsutism as the referral diagnosis. Fertil Steril 82:1570-1579
40. Carmina E, Rosato F, Janni A, Rizzo M, Longo RA 2006 Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism. J Clin Endocrinol Metab 91:2-6
41. Gillis D, Speiser P, Zhou Z, Rosler A 2000 Combined 21-hydroxylase and 11β-hydroxylase deficiency: patient report and molecular basis. J Pediatr Endocrinol Metab 13:945-949
42. Moran C, Azziz R, Weintrob N, Witchel SF, Rohmer V, Dewailly D, Marcondes JA, Pugeat M, Speiser PW, Pignatelli D, Mendonca BB, Bachega TA, Escobar-Morreale HF, Carmina E, Fruzzetti F, Kelestimur F 2006 Reproductive outcome of women with 21-hydroxylase-deficient nonclassic adrenal hyperplasia. J Clin Endocrinol Metab 91:3451-3456